AU8164298A - Salt complex for lymphatic delivery - Google Patents

Salt complex for lymphatic delivery

Info

Publication number
AU8164298A
AU8164298A AU81642/98A AU8164298A AU8164298A AU 8164298 A AU8164298 A AU 8164298A AU 81642/98 A AU81642/98 A AU 81642/98A AU 8164298 A AU8164298 A AU 8164298A AU 8164298 A AU8164298 A AU 8164298A
Authority
AU
Australia
Prior art keywords
salt complex
lymphatic delivery
lymphatic
delivery
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81642/98A
Inventor
Lee Roy Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dekk Tek Inc
Original Assignee
Dekk Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dekk Tek Inc filed Critical Dekk Tek Inc
Publication of AU8164298A publication Critical patent/AU8164298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU81642/98A 1997-06-23 1998-06-23 Salt complex for lymphatic delivery Abandoned AU8164298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5053197P 1997-06-23 1997-06-23
US60050531 1997-06-23
PCT/US1998/013083 WO1998058649A1 (en) 1997-06-23 1998-06-23 Salt complex for lymphatic delivery

Publications (1)

Publication Number Publication Date
AU8164298A true AU8164298A (en) 1999-01-04

Family

ID=21965785

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81642/98A Abandoned AU8164298A (en) 1997-06-23 1998-06-23 Salt complex for lymphatic delivery

Country Status (2)

Country Link
AU (1) AU8164298A (en)
WO (1) WO1998058649A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200800145A (en) * 2005-08-26 2008-01-01 Dekk Tec Inc Hydrazone agents to treat cutaneous lesions
US10632081B2 (en) 2014-10-14 2020-04-28 Industrial Technology Research Institute Intralymphatic delivery of hyaluronan nanoparticle for cancer metastasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270172A (en) * 1991-04-26 1993-12-14 Dekk-Tek, Inc. Method to predict tumor response to therapy

Also Published As

Publication number Publication date
WO1998058649A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
AU7077098A (en) Transdermal delivery system
GB9711237D0 (en) Organomettallic Complexes
AU5387898A (en) Pharmaceutical agents
AU747434C (en) Dispenser apparatus
AU8591898A (en) Pharmaceutical compounds
AU6818998A (en) Machine
AU4090299A (en) Liposomal delivery complex
AU9650398A (en) Piperazine-cyclodextrin complexes
AUPO759797A0 (en) Dispenser
AUPO692897A0 (en) Dispensing means
AU6673898A (en) Factor x variant
AU8072498A (en) Heregulin-like factor
AU5787498A (en) Dosage machine
AU1171099A (en) Therapeutic agents
AU6000498A (en) Compounds for use in adept
EP1449945A3 (en) Spin-drawtexturing- or drawtexturing machine
AU8164298A (en) Salt complex for lymphatic delivery
AU1265299A (en) Pump
AU8333698A (en) Dispenser
AU8333598A (en) Dispensing system
AU6192298A (en) New naphthylpiperazine derivatives
AU1899099A (en) Agents
AU1693699A (en) Pump
AU6529098A (en) Dispenser
GB9702852D0 (en) Rotary pump

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase